mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases (2018)
Attributed to:
Synthetic viability: a novel approach to defining healthspan determinants
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.20944/preprints201806.0056.v1
Publication URI: http://dx.doi.org/10.20944/preprints201806.0056.v1
Type: Preprint